GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

President Donald Trump unquestionably secured a big win as the conservative Supreme Court wrapped up its term this past week, but there were signs that the administration’s long-running feud with the ...